V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016986 | 160018214 | 0 | 10.2 | Palliative (P) | 2017-07-25 | 2018-11-04 | ETOPOSIDE | 02 | N | NB HRNBL-1 BUMEL MAT | 100200365 |
| 160016988 | 160018215 | 1.71 | 93.9 | Neo-adjuvant (N) | 2019-01-22 | 2019-02-02 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | GEMCITABINE | 100910350 |
| 160016990 | 160018216 | null | 16.8 | null | 2021-11-14 | 2021-11-16 | NB HRNBL-1 TVD | 02 | N | BRIGATINIB | 101822042 |
| 160016993 | 160018217 | 1.6 | 26 | Palliative (P) | 2017-07-04 | 2017-07-07 | EW EuroEwing 2012 Arm B IE | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 100212183 |
| 160016996 | 160018218 | 1.78 | 21.8 | Adjuvant (A) | 2020-03-23 | 2020-09-21 | CARBOPLATIN + GEMCITABINE | 01 | N | EW EUROEWING 2012 ARM B VC | 100086284 |
| 160017000 | 160018219 | 1.86 | 51.9 | null | 2018-03-05 | 2018-03-21 | Ifosfamide | 02 | null | CISPLATIN + ETOPOSIDE | 101514865 |
| 160017009 | 160018220 | 1.56 | 63.5 | Palliative (P) | 2019-08-26 | 2019-08-28 | WT SIOP 2002 01 post op VA | 02 | N | EW EUROEWING 2012 ARM A VAC | 101316985 |
| 160017011 | 160018221 | 1.73 | 66.9 | Palliative (P) | 2018-09-08 | 2018-09-21 | PEMBROLIZUMAB | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100970885 |
| 160017014 | 160018222 | 1.4 | 87.6 | Curative (C) | 2016-05-13 | 2016-05-18 | ETOP 13-18 BEAT-meso Trial | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101467040 |
| 160017019 | 160018223 | 1.62 | 57.5 | null | 2017-02-02 | 2018-03-28 | PROMISE-MESO TRIAL | 02 | null | TRIAL | 100745063 |
| 160017024 | 160018224 | 1.8 | 73.8 | 03 | 2017-07-29 | 2017-07-29 | EW EuroEwing 2012 Arm B VC | 02 | null | CYCLOPHOSPHAMIDE | 101513533 |
| 160017043 | 160018227 | 1.75 | 19.1 | Adjuvant (A) | 2017-06-29 | 2017-06-29 | ATOMIC-MESO TRIAL | 02 | N | ERIBULIN | 101658857 |
| 160017044 | 160018228 | 1.62 | 55.1 | Palliative (P) | 2017-06-05 | 2018-01-18 | Niraparib | 02 | N | GEMCITABINE | 101125629 |
| 160017045 | 160018229 | 1.63 | 91.1 | Palliative (P) | 2019-07-21 | 2019-10-29 | BUSULFAN + MELPHALAN | 01 | N | EW EUROEWING 2012 ARM A VAC | 100263234 |
| 160017052 | 160018230 | null | 26.1 | Palliative (P) | 2017-09-07 | 2017-10-17 | Etoposide oral | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100940818 |
| 160017053 | 160018231 | 1.67 | 72.4 | Palliative (P) | 2019-04-28 | 2019-05-13 | Dacarbazine | N | N | PEMBROLIZUMAB | 100949152 |
| 160017054 | 160018232 | null | 77.6 | null | 2020-11-15 | 2021-11-23 | NEMO TRIAL | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101068411 |
| 160017067 | 160018233 | 0 | 38.1 | Curative (C) | 2020-08-16 | 2020-09-25 | GEMCITABINE | N | N | TRIAL | 100157495 |
| 160017076 | 160018234 | 0 | 10.8 | null | 2019-08-20 | 2019-11-07 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | GEMCITABINE | 101525979 |
| 160017078 | 160018235 | 1.63 | 37 | Palliative (P) | null | 2018-11-04 | ETOPOSIDE | 02 | N | NB HRNBL-1 BUMEL MAT | 101464795 |
| 160017091 | 160018236 | null | 69.8 | Curative (C) | 2018-10-06 | 2018-10-09 | STS Rhabdo RMS 2005 Vin Cyclo | 01 | N | CONFIRM TRIAL | 101284569 |
| 160017106 | 160018237 | 0 | 14.4 | null | 2020-11-07 | 2020-11-25 | CABOZANTINIB | 02 | null | ETOPOSIDE | 100451101 |
| 160017119 | 160018238 | 1.62 | 77.75 | Palliative (P) | 2019-11-20 | 2020-06-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | GEMCITABINE | 100674859 |
| 160017127 | 160018239 | 0 | 100.4 | Palliative (P) | 2021-10-02 | 2021-11-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | BEP | 101584547 |
| 160017128 | 160018240 | null | null | Curative (C) | 2017-03-04 | 2017-03-10 | ETOP 13-18 BEAT-meso Trial | N | Y | OLAPARIB | 100315424 |
| 160017140 | 160018241 | null | 91.8 | null | 2020-05-25 | 2020-10-29 | null | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100022048 |
| 160017143 | 160018242 | 1.69 | 77.3 | Palliative (P) | 2021-02-23 | 2021-09-22 | BUSULFAN + MELPHALAN | 02 | N | LENALIDOMIDE | 101237274 |
| 160017144 | 160018243 | 1.67 | 55 | null | 2017-08-26 | 2017-10-04 | Cisplatin 7 day | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 101293282 |
| 160017151 | 160018244 | 0 | 74 | Curative (C) | 2017-09-17 | 2017-09-17 | Cyclophosphamide + Topotecan | 02 | N | IFOSFAMIDE | 101212727 |
| 160017158 | 160018245 | 1.85 | 83.6 | Curative (C) | 2018-07-30 | 2018-10-16 | VIDE | 02 | N | PEMBROLIZUMAB | 101600360 |
| 160017159 | 160018246 | 1.7 | 114.6 | Palliative (P) | null | 2020-10-02 | Gemcitabine day 1&8 | 02 | null | POMALIDOMIDE | 101794810 |
| 160017162 | 160018247 | null | 100.5 | null | 2020-08-13 | 2020-08-13 | Ifosfamide | N | null | RUCAPARIB | 100936393 |
| 160017164 | 160018248 | 1.63 | 108.35 | Palliative (P) | 2020-05-10 | 2020-06-07 | BEP 5 Day | 02 | N | NB HRNBL-1 ISOTRETINOIN | 100139910 |
| 160017165 | 160018249 | 1.71 | 89.8 | Curative (C) | 2018-10-04 | 2018-11-03 | EW EuroEwing 2012 Arm A VIDE | 02 | N | POMALIDOMIDE | 100739403 |
| 160017174 | 160018250 | 1.74 | 94 | null | 2019-03-26 | 2019-03-27 | MESO-02 TRIAL | 02 | N | RUCAPARIB | 100074163 |
| 160017176 | 160018251 | 1.77 | 75 | Palliative (P) | 2019-11-05 | 2019-11-13 | CYCLOPHOSPHAMIDE | 02 | N | NIRAPARIB | 100445707 |
| 160017179 | 160018252 | 1.4 | 65 | null | 2014-11-15 | 2014-11-22 | LENALIDOMIDE | 02 | null | CAPECITABINE + OXALIPLATIN | 100043144 |
| 160017182 | 160018253 | 1.7 | 110.7 | Palliative (P) | 2021-07-17 | 2021-07-18 | Etoposide oral | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100369669 |
| 160017187 | 160018254 | null | 109 | null | 2018-09-01 | 2019-08-16 | VINCRISTINE | N | null | ETOPOSIDE + IFOSFAMIDE | 100982620 |
| 160017190 | 160018255 | 1.64 | 12.6 | null | 2019-04-30 | 2019-05-15 | NB HRNBL-1 MOD N7 PE | 02 | N | STS RHABDO RMS 2005 | 101300246 |
| 160017194 | 160018256 | 1.58 | 82.2 | 03 | 2020-05-11 | 2020-05-11 | Gemcitabine day 1&8 | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101188298 |
| 160017196 | 160018257 | 1.61 | 52.15 | 03 | 2018-01-09 | 2018-04-08 | Doxorubicin + Ifosfamide | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100729238 |
| 160017212 | 160018259 | null | null | Curative (C) | 2019-01-27 | 2019-03-03 | DOCETAXEL + TRASTUZUMAB | 02 | N | CREATE TRIAL | 101707123 |
| 160017216 | 160018260 | 1.56 | 63.9 | null | 2017-12-03 | 2019-02-18 | Cyclophosphamide + Vincristine | 02 | null | RUCAPARIB | 101196585 |
| 160017219 | 160018261 | 1.43 | 85.4 | Adjuvant (A) | 2016-12-03 | 2016-12-05 | GEMCITABINE | 99 | N | EW EUROEWING 2012 ARM B VC | 101529211 |
| 160017220 | 160018262 | 1.64 | 19.2 | null | 2016-10-14 | 2016-11-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101402976 |
| 160017222 | 160018263 | 0 | 70.2 | Curative (C) | 2019-09-26 | 2019-09-26 | MELPHALAN | 02 | N | IPILIMUMAB + NIVOLUMAB | 100311295 |
| 160017227 | 160018264 | 1.88 | 84.4 | Curative (C) | 2018-09-16 | 2018-09-16 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | IFOSFAMIDE | 100296549 |
| 160017246 | 160018265 | 0 | 56.4 | Palliative (P) | 2018-05-24 | 2018-06-25 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | GEMCITABINE + TREOSULFAN | 100598433 |
| 160017251 | 160018266 | 1.81 | 77.5 | Palliative (P) | 2018-03-12 | 2018-03-19 | Venetoclax | 01 | N | ETOPOSIDE | 101434073 |